InvaGen Pharma gets USFDA approval for neuropathic pain management drug | Business Standard News - WorldMixture

0

Business
InvaGen Pharma gets USFDA approval for neuropathic pain management drug | Business Standard News

approved equivalent therapeutic

Tejal Sandera 155 2043 days ago

Cipla said the approved product is a generic therapeutic equivalent version of Pfizer's Lyrica
- Read full article

Related Articles

GLOBAL MARKETS-World shares face end to ...

Open that door? Netflix explores choose-...

INSIGHT-Counting the cost: Nissan unpick...

UPDATE 1-Trial of former Nissan boss Gho...

EMERGING MARKETS-Emerging market stocks ...

UPDATE 2-Hydro working to restore operat...

PRECIOUS-Palladium hits record high; gol...

UPDATE 1-Kazakh tenge slips after vetera...

Trial of former Nissan boss Ghosn expect...

Leave a Comment

Please Login to insert comment.

Facebook Conversations